T1	HMM 368 488	LCS6 genotype and its association with KRAS mutation status, clinicopathologic features, and disease-free survival (DFS)
T2	HMM 816 833	and KRAS mutation
T3	HMM 1024 1045	(15.2%) blood samples
T4	HMM 1054 1124	(14.6%) tumor samples heterozygous or homozygous for the LCS6 G-allele
T5	HMM 1182 1237	(85.4%) tumor samples homozygous for the LCS6 T-allele.
T6	HMM 1238 1254	Genotype results
T7	HMM 1339 1340	.
T8	HMM 1341 1358	G-allele carriers
T9	HMM 1451 1468	The LCS6 genotype
T10	HMM 1488 1541	with KRAS mutation status, clinicopathologic features
T11	HMM 1557 1563	or DFS
T12	HMM 1667 1692	with KRAS mutation status
